EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Assuming you can get your hands on a COVID-19 home test kit — they’ve been in high demand, thanks to the omicron variant — you probably have questions. Am I testing too early or late? Is this brand or ...

Transformative Biotech LLC, a Boulder-based company working to develop faster molecular tests for diseases such as COVID-19 and cancer, has appointed Mark Kelleher as executive vice president of ...

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.

Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization (EUA) ...

After the start of the SARS-C0V-2 pandemic, investigators from ResearchPath LLC and their collaborators at Rutgers University quickly dedicated resources to develop accurate and reliable COVID-19 ...

Lateral flow tests (LFTs) are quick and easy to take at home, giving a result within 20-30 minutes. They look for proteins on the surface of the virus, which are easily detected. However, they have a ...

A new highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received emergency use authorization (EUA) status from the US Food and Drug Administration (FDA).

Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...

The EXPANDIA project demonstrates how cross-sector partnerships and RT-LAMP diagnostics can expand testing capacity in ...